Clinical Trial Details
| Trial ID: | L1614 |
| Source ID: | NCT00255424 |
| Associated Drug: | Ferumoxytol Or Oral Iron |
| Title: | Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Anemia |
| Interventions: | DRUG: ferumoxytol or oral iron |
| Outcome Measures: | Primary: The mean change in hemoglobin from baseline. | Secondary: Change in iron indices. |
| Sponsor/Collaborators: | Sponsor: AMAG Pharmaceuticals, Inc. |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE3 |
| Enrollment: | 304 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2004-05 |
| Completion Date: | 2006-08 |
| Results First Posted: | |
| Last Update Posted: | 2015-01-09 |
| Locations: | Encino, California, 91356, United States|Riverside, California, 92501, United States|Tarzana, California, 91356, United States|Ocala, Florida, 34471, United States|Shreveport, Louisiana, 71101, United States|Shreveport, Louisiana, 71103, United States|Springfield, Massachusetts, 01107, United States|Detroit, Michigan, 48236, United States|Flushing, New York, 11355, United States|Orchard Park, New York, 14127, United States|Columbus, Ohio, 43210, United States|Hershey, Pennsylvania, 17033, United States|Lancaster, Pennsylvania, 17604, United States|Chattanooga, Tennessee, 37404, United States|Knoxville, Tennessee, 37923, United States|Houston, Texas, 77074, United States|Fairfax, Virginia, 22030, United States|Bluefield, West Virginia, 24701, United States|Appleton, Wisconsin, 54911, United States |
| URL: | https://clinicaltrials.gov/show/NCT00255424 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|